GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Guggenheim Enhanced Equity Income Fund (NYSE:GPM) » Definitions » Sloan Ratio %

Guggenheim Enhanced Equityome Fund (Guggenheim Enhanced Equityome Fund) Sloan Ratio % : 0.00% (As of Jun. 2021)


View and export this data going back to . Start your Free Trial

What is Guggenheim Enhanced Equityome Fund Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Guggenheim Enhanced Equityome Fund's Sloan Ratio for the quarter that ended in Jun. 2021 was 0.00%.

As of Jun. 2021, Guggenheim Enhanced Equityome Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Guggenheim Enhanced Equityome Fund Sloan Ratio % Historical Data

The historical data trend for Guggenheim Enhanced Equityome Fund's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guggenheim Enhanced Equityome Fund Sloan Ratio % Chart

Guggenheim Enhanced Equityome Fund Annual Data
Trend Dec17 Dec18 Dec19 Dec20
Sloan Ratio %
- - - -

Guggenheim Enhanced Equityome Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Sloan Ratio % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Guggenheim Enhanced Equityome Fund's Sloan Ratio %

For the Asset Management subindustry, Guggenheim Enhanced Equityome Fund's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guggenheim Enhanced Equityome Fund's Sloan Ratio % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Guggenheim Enhanced Equityome Fund's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Guggenheim Enhanced Equityome Fund's Sloan Ratio % falls into.



Guggenheim Enhanced Equityome Fund Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Guggenheim Enhanced Equityome Fund's Sloan Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2020 )-Cash Flow from Operations (A: Dec. 2020 )
-Cash Flow from Investing (A: Dec. 2020 ))/Total Assets (A: Dec. 2020 )
=(-0.58-44.363
-0)/524.213
=-8.57%

Guggenheim Enhanced Equityome Fund's Sloan Ratio for the quarter that ended in Jun. 2021 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2021 )
=(152.892--38.796
-0)/620.615
=30.89%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Guggenheim Enhanced Equityome Fund's Net Income for the trailing twelve months (TTM) ended in Jun. 2021 was 77.392 (Dec. 2020 ) + 75.5 (Jun. 2021 ) = $152.9 Mil.
Guggenheim Enhanced Equityome Fund's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2021 was -19.316 (Dec. 2020 ) + -19.48 (Jun. 2021 ) = $-38.8 Mil.
Guggenheim Enhanced Equityome Fund's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2021 was 0 (Dec. 2020 ) + 0 (Jun. 2021 ) = $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guggenheim Enhanced Equityome Fund  (NYSE:GPM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2021, Guggenheim Enhanced Equityome Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Guggenheim Enhanced Equityome Fund Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Guggenheim Enhanced Equityome Fund's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guggenheim Enhanced Equityome Fund (Guggenheim Enhanced Equityome Fund) Business Description

Traded in Other Exchanges
N/A
Address
227 West Monroe Street, Chicago, IL, USA, 60606
Guggenheim Enhanced Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income and gains with a secondary objective of long-term capital appreciation. The fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities.
Executives
Hollowell Iii Orenzo Perry other: Portfolio Manager 330 MADISON AVENUE, NEW YORK NY 10017
Toupin Ronald E Jr director, other: Trustee 117 ASHLAND AVENUE, RIVER FOREST IL 60305
Lydon Thomas F Jr director, other: Trustee
Angela Brock-kyle director, other: Trustee 3700 COLONNADE PARKWAY, BIRMINGHAM AL 35243
Sandra G Sponem director, other: Trustee 800 NICOLLET MALL, J1012057, MINNEAPOLIS MN 55402-7020
William Rehder officer: Assistant Vice President 227 W MONROE STREET, CHICAGO IL 60606
Maynard F. Oliverius director, other: Trustee 2455 CORPORATE WEST DRIVE, LISLE IL 60532
Jon Szafran officer: Assistant Treasurer 227 W. MONROE STREET, CHICAGO IL 60606
Brian E. Binder officer: President and CEO C/O ANJIE LAROCCA, DEUTSCHE BANK, 60 WALL STREET, NEW YORK NY 11752
Randall C Barnes director, other: Trustee 2455 CORPORATE WEST DRIVE, LISLE IL 60187
Scott A Hammond other: Portfolio Manager 227 W. MONROE STREET CHICAGO IL 60606
Keith David Kemp officer: Assistant Treasurer MACQUARIE FUND ADVISER LLC, 125 WEST 55TH STREET, NEW YORK NY 10019
Glenn Mcwhinnie officer: Assistant Treasurer 227 W. MONROE STREET, CHICAGO IL 60606
Qi Yan other: Portfolio Manager 100 WILSHIRE BOULEVARD SANTA MONICA CA 90401
Adam J Nelson officer: Assistant Treasurer 227 WEST MONROE STREET, CHICAGO IL 60606